| 000 | 01207 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514012005.0 | ||
| 264 | 0 | _c20020306 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a1434-6621 | ||
| 024 | 7 |
_a10.1515/CCLM.2001.117 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aden Heijer, M | |
| 245 | 0 | 0 |
_aHyperhomocysteinemia as a risk factor for venous thrombosis. _h[electronic resource] |
| 260 |
_bClinical chemistry and laboratory medicine _cAug 2001 |
||
| 300 |
_a710-3 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aFactor V _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperhomocysteinemia _xmetabolism |
| 650 | 0 | 4 | _aMethylenetetrahydrofolate Reductase (NADPH2) |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 |
_aOxidoreductases Acting on CH-NH Group Donors _xgenetics |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aVascular Diseases _xgenetics |
| 650 | 0 | 4 |
_aVenous Thrombosis _xgenetics |
| 700 | 1 | _aKeijzer, M B | |
| 773 | 0 |
_tClinical chemistry and laboratory medicine _gvol. 39 _gno. 8 _gp. 710-3 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1515/CCLM.2001.117 _zAvailable from publisher's website |
| 999 |
_c11512580 _d11512580 |
||